» Articles » PMID: 25047712

Structural and Functional Analysis of the Anti-malarial Drug Target Prolyl-tRNA Synthetase

Overview
Specialty Genetics
Date 2014 Jul 23
PMID 25047712
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Aminoacyl-tRNA synthetases (aaRSs) drive protein translation in cells and hence these are essential enzymes across life. Inhibition of these enzymes can halt growth of an organism by stalling protein translation. Therefore, small molecule targeting of aaRS active sites is an attractive avenue from the perspective of developing anti-infectives. Febrifugine and its derivatives like halofuginone (HF) are known to inhibit prolyl-tRNA synthetase of malaria parasite Plasmodium falciparum. Here, we present functional and crystallographic data on P. falciparum prolyl-tRNA synthetase (PfPRS). Using immunofluorescence data, we show that PfPRS is exclusively resident in the parasite cytoplasm within asexual blood stage parasites. The inhibitor HF interacts strongly with PfPRS in a non-competitive binding mode in presence or absence of ATP analog. Intriguingly, the two monomers that constitute dimeric PfPRS display significantly different conformations in their active site regions. The structural analyses presented here provide a framework for development of febrifugine derivatives that can seed development of new anti-malarials.

Citing Articles

The Plethora of RNA-Protein Interactions Model a Basis for RNA Therapies.

Dansereau S, Cui H, Dartawan R, Sheng J Genes (Basel). 2025; 16(1).

PMID: 39858595 PMC: 11765398. DOI: 10.3390/genes16010048.


ATP mimetics targeting prolyl-tRNA synthetases as a new avenue for antimalarial drug development.

Mishra S, Malhotra N, Laleu B, Chakraborti S, Yogavel M, Sharma A iScience. 2024; 27(7):110049.

PMID: 39104570 PMC: 11298890. DOI: 10.1016/j.isci.2024.110049.


Aminoacyl tRNA Synthetases: Implications of Structural Biology in Drug Development against Trypanosomatid Parasites.

Nasim F, Qureshi I ACS Omega. 2023; 8(17):14884-14899.

PMID: 37151504 PMC: 10157851. DOI: 10.1021/acsomega.3c00826.


Computational screening of FDA-approved drugs to identify potential TgDHFR, TgPRS, and TgCDPK1 proteins inhibitors against Toxoplasma gondii.

Gharibi Z, Shahbazi B, Gouklani H, Nassira H, Rezaei Z, Ahmadi K Sci Rep. 2023; 13(1):5396.

PMID: 37012275 PMC: 10070243. DOI: 10.1038/s41598-023-32388-9.


Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis.

Yogavel M, Bougdour A, Mishra S, Malhotra N, Chhibber-Goel J, Bellini V PLoS Pathog. 2023; 19(2):e1011124.

PMID: 36854028 PMC: 9974123. DOI: 10.1371/journal.ppat.1011124.


References
1.
Kobayashi S, Ueno M, Suzuki R, Ishitani H, Kim H, Wataya Y . Catalytic Asymmetric Synthesis of Antimalarial Alkaloids Febrifugine and Isofebrifugine and Their Biological Activity. J Org Chem. 2001; 64(18):6833-6841. DOI: 10.1021/jo990877k. View

2.
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

3.
Chen V, Arendall 3rd W, Headd J, Keedy D, Immormino R, Kapral G . MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 1):12-21. PMC: 2803126. DOI: 10.1107/S0907444909042073. View

4.
Zhu S, Wang J, Chandrashekar G, Smith E, Liu X, Zhang Y . Synthesis and evaluation of 4-quinazolinone compounds as potential antimalarial agents. Eur J Med Chem. 2010; 45(9):3864-9. PMC: 2918702. DOI: 10.1016/j.ejmech.2010.05.040. View

5.
Hora R, Bridges D, Craig A, Sharma A . Erythrocytic casein kinase II regulates cytoadherence of Plasmodium falciparum-infected red blood cells. J Biol Chem. 2009; 284(10):6260-9. PMC: 2649111. DOI: 10.1074/jbc.M809756200. View